Publications by authors named "Justin Yu Kuan Tan"
Cancer Manag Res
January 2023
Article Synopsis
- Anaplastic lymphoma kinase (ALK) inhibitors are effective for ALK-positive metastatic non-small cell lung cancer (NSCLC), but access is limited in developing countries like Malaysia due to financial constraints.
- A study analyzed 65 ALK-positive NSCLC patients from 18 Malaysian hospitals, finding that most received crizotinib, the most common ALK inhibitor, and showed improved overall survival (OS) compared to those on chemotherapy.
- Although ALK inhibitors led to a longer median time on treatment (TOT) and OS, the results were not statistically significant likely due to the small sample size.
